Chiang Whei-Ling, Hsieh Yih-Shou, Yang Shun-Fa, Lu Tsang-An, Chu Shu-Chen
School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan.
Clin Chim Acta. 2007 Jan;375(1-2):110-4. doi: 10.1016/j.cca.2006.06.023. Epub 2006 Jun 27.
Published reports concerning the expression of GST in various anemias including aplastic, hemolytic, iron deficiency and thalassemia anemia has been insufficient. We improved the conventional GST assay by incorporating a chloroform treatment to remove the interference of hemoglobin and evaluated the altered expression of GSTs in various anemias in Taiwan.
We incorporated a chloroform treatment to eliminate the interference of hemoglobin. Erythrocyte total GST and isoenzymes activities from 35 control subjects and 125 subjects of various anemias, including aplastic, hemolytic, iron deficiency and thalassemia anemias were measured spectrophotometrically.
Chloroform treatment did not significantly affect GST activities in erythrocytes of control subjects while the activities of erythrocyte total GST and alpha-GST were significantly increased in all anemic patients (P<0.001). The expression of mu-GST was significantly decreased, although at a less extent, in cases of aplastic, iron deficiency and thalassemia anemia (P<0.05), but pi-GST was not physiologically different in various types of anemia.
The determination of changes in erythrocyte GST activity is a promising indicator of oxidative stress conditions that occur in various types of anemia. Measurement of GST activity might be useful for the evaluation of prophylactic treatment in trials of antioxidant strategies.
关于谷胱甘肽S-转移酶(GST)在包括再生障碍性贫血、溶血性贫血、缺铁性贫血和地中海贫血在内的各种贫血中的表达,已发表的报告并不充分。我们通过采用氯仿处理来去除血红蛋白的干扰,改进了传统的GST检测方法,并评估了台湾地区各种贫血中GSTs表达的变化。
我们采用氯仿处理以消除血红蛋白的干扰。用分光光度法测定了35名对照受试者和125名各种贫血受试者(包括再生障碍性贫血、溶血性贫血、缺铁性贫血和地中海贫血患者)红细胞中的总GST和同工酶活性。
氯仿处理对对照受试者红细胞中的GST活性没有显著影响,而所有贫血患者红细胞中的总GST和α-GST活性均显著增加(P<0.001)。在再生障碍性贫血、缺铁性贫血和地中海贫血患者中,μ-GST的表达显著降低,尽管降低程度较小(P<0.05),但在各种类型的贫血中,π-GST在生理上并无差异。
测定红细胞GST活性的变化是各种类型贫血中氧化应激状态的一个有前景的指标。在抗氧化策略试验中,测量GST活性可能有助于预防性治疗的评估。